MEDICAL DISCLAIMER: Educational research guidelines only. Lyophilized peptides are investigational chemical compounds and are NOT approved for human consumption, diagnosis, or therapy. Consult a licensed physician before any research application.
Svetinorm Dosage Chart, Schedule & Reconstitution Protocol
Quickstart Highlights
Svetinorm (Liver Cytomax A-7) is a natural Khavinson liver peptide bioregulator, a cytamin extracted from calf and pig liver and sold as enteric capsules. Rather than acting as a receptor ligand, its short peptides are proposed to enter the hepatocyte nucleus and nudge expression of liver-maintenance, antioxidant and protein-synthesis genes (PMID 32362099, 34834147). Experimental liver polypeptide-complex studies report normalized transaminases and restored antioxidant status in hepatitis models, with the strongest effects in aged animals, but no randomized human trials of the finished product exist (PMID 19830585). It is an unapproved dietary supplement, not an FDA or EMA approved drug. The established oral dose is about 10 mg of A-7 complex per capsule, 1-2 capsules once or twice daily with meals for 30 days, repeated every 3-6 months. The subcutaneous schedule on this page is an educational reconstitution reference: a 20 mg vial in 2 mL of bacteriostatic water gives 10 mg/mL, so 0.2-0.6 mg is 2-6 units.
Reconstitute: Add 2 mL bacteriostatic water → 10 mg/mL concentration.
Typical dose: 10-40 mg/day oral (1-2 capsules, 1-2x daily)
Easy measuring: At 10 mg/mL, 1 unit = 0.01 mL = 0.1 mg (100 mcg) on a U-100 insulin syringe.
Storage: Capsules: store dry at room temperature, below 25°C, away from light. Educational reference vial: keep lyophilized powder at 2-8°C (frozen for long-term storage); once reconstituted, refrigerate at 2-8°C and avoid repeated freeze-thaw.
Half-life: Not formally characterized; the short peptides are hydrolyzed within minutes and effects are attributed to downstream gene-expression changes.
Route: Oral enteric capsules (~10 mg A-7 complex each) in real use; the subcutaneous figures here are an educational reconstitution reference.
Status: Not FDA or EMA approved; a Khavinson cytamin sold as a dietary supplement and for research use only.
About Svetinorm
Svetinorm (Liver Cytomax A-7) is a natural Khavinson liver peptide bioregulator. In real-world use it is an oral enteric capsule, not an injection: each capsule supplies roughly 10 mg of the liver-derived A-7 peptide complex, and the validated Svetinorm dosage is 1-2 capsules taken once or twice daily with food across a 30-day course [8]. The subcutaneous figures below are an educational reconstitution reference modeled on the lyophilized liver-cytomedin analog of this class, not a clinically established injectable regimen [1][2].\n\nEducational guide for reconstitution and daily dosing.\n\nFrequency: For the oral product, take capsules with meals for about 30 days, repeating the course every 3-6 months. For the subcutaneous reconstitution reference, inject once daily. Reconstituting a 20 mg vial with 2 mL of bacteriostatic water yields 10 mg/mL, so a 0.2-0.6 mg educational dose corresponds to 2-6 units on a U-100 insulin syringe [8].
Quick Protocol Navigation
Reconstitution Instruction & Mixing Step-by-Step
Lyophilized powder must be reconstituted carefully. Agitating peptide chains can shear disulfide bonds and render the peptide biologically inert.
Draw 2.0 mL of bacteriostatic water into a sterile syringe.
Inject the water slowly down the inside wall of the 20 mg Svetinorm vial; do not spray it directly onto the powder.
Gently swirl or roll the vial until fully dissolved; never shake, which can foam and damage peptide.
Swab the stopper, then draw your dose: at 10 mg/mL, 2-6 units on a U-100 syringe equals 0.2-0.6 mg.
Inject subcutaneously, withdraw after a few seconds, and store the reconstituted vial refrigerated at 2-8°C; avoid freeze-thaw.
Interactive Svetinorm Syringe Calculator
Currently visualizing the 20 mg vial reconstituted with 2 mL bacteriostatic water. Adjust the target dose to dynamically render syringe units.
Reconstitution Calculation: 20mg dry powder in 2mL water yields 10.00 mg/mL. To evaluate a 250mcg dose, pull to 2.5 units (3 syringe ticks).
U-100 Syringe Representation
Educational reference visual. Assumes standard U-100 insulin syringe where 1.0 mL volume = 100 units.
Titration & Dose Escalation Schedules
| Phase | Dose per injection | Units (per injection) |
|---|---|---|
| Days 1-7 (introduction) | 200 mcg | 2 units (0.02 mL) |
| Days 8-20 (standard course) | 400 mcg | 4 units (0.04 mL) |
| Days 21-30 (full course) | 600 mcg | 6 units (0.06 mL) |
Administration guidelines: Refer to guidelines | 2 mL Reconstitution
Research Supplies Quantity Planner
Scientific mathematical planning of syringes, bacteriostatic water and dry vials needed for extended research blocks using the 20 mg vial.
Peptide Vials (Svetinorm, 20 mg each):
- check8-week reference course (~400 mcg/day, ~22 mg total): 2 vials
- check12-week course (~34 mg total): 2 vials
- check16-week course (~45 mg total): 3 vials
- checkReal-world oral course (30 days) is separate: 1 bottle of 20-60 capsules
Insulin Syringes (U-100):
- checkPer week: 7 syringes (once daily)
- check8 weeks: 56 syringes
- check12 weeks: 84 syringes
- check16 weeks: 112 syringes (order ~120 with spares)
Bacteriostatic Water (10 mL bottles): Use 2 mL per vial for reconstitution.
- check8 weeks (2 vials): 4 mL
- check12 weeks (2 vials): 4 mL
- check16 weeks (3 vials): 6 mL
- checkA single 10 mL bottle covers any of these courses
Alcohol Swabs: One for the vial stopper plus one for the injection site each day.
- checkPer week: 14 swabs (2/day)
- check8 weeks: 112 swabs
- check12 weeks: 168 swabs
- check16 weeks: 224 swabs (2-3 boxes of 100)
Mechanism of Action (MOA)
Svetinorm is a cytamin: a natural peptide bioregulator obtained by patented extraction of short polypeptide fractions from the livers of young calves and pigs, then purified and formulated as enteric capsules. It sits within Vladimir Khavinson's tissue-specific bioregulator program at the St. Petersburg Institute of Bioregulation and Gerontology, alongside the injectable cytomedins and the synthetic cytogen analogs (the liver cytogen is the tripeptide Ovagen) [2][5]. The labeled active is the "A-7" liver peptide complex (about 10 mg per capsule), accompanied by free amino acids including glutamic acid, aspartic acid, glycine, arginine, tyrosine, alanine, leucine, valine, isoleucine, histidine, proline and serine [8].\n\nMechanistically, the Khavinson model holds that these very short peptides are not classical receptor ligands. Instead, a small fraction is proposed to reach the cytoplasm and nucleus, where the peptides form complementary contacts with specific promoter nucleotide sequences and modulate transcription of tissue-appropriate genes [3]. For a liver bioregulator the proposed targets are hepatocyte-maintenance programs: albumin and other secretory-protein synthesis, detoxification enzymes, and antioxidant-response genes. Experimental work on a liver polypeptide complex and the related liver tetrapeptide KEDA reports normalized immune and antioxidant status and restored hepatic function in models of acute and chronic hepatitis, with the most pronounced effects in aged animals [1].\n\nPharmacokinetics have not been formally characterized for Svetinorm. As a mixture of short peptides and amino acids it is expected to be rapidly hydrolyzed by gastrointestinal and plasma peptidases, so the free-peptide plasma half-life is on the order of minutes; any durable effect is attributed to downstream changes in gene expression rather than sustained circulating peptide [3][4]. Oral bioavailability of intact peptide is low, which is why the product uses enteric capsules and why parenteral cytomedin analogs of the same class are also manufactured.\n\nRoute honesty matters here: clinically Svetinorm is taken by mouth. The subcutaneous figures on this page are an educational reconstitution reference modeled on the lyophilized liver-cytomedin analog of the Khavinson class, not a validated injectable regimen [8]. Reconstituting a 20 mg vial in 2 mL of bacteriostatic water gives 10 mg/mL, so the illustrative 0.2-0.6 mg per administration corresponds to 2-6 units on a U-100 syringe.\n\nThe real-world protocol is a 30-day oral course of 1-2 capsules once or twice daily with meals, repeated every 3-6 months, and often cycled alongside other organ-specific bioregulators (for example Endoluten, Vladonix, Cerluten, Sigumir and Ventfort) [8]. Svetinorm remains an unapproved dietary-supplement and research bioregulator with no published randomized human trials, so all dosing here is reference information only [4][5].
Clinical Trial Efficacy Highlights
- starIn experimental models of acute and chronic hepatitis and liver fibrosis, a liver-derived polypeptide complex together with the related liver tetrapeptide KEDA normalized immune and antioxidant status and restored hepatic function, with the largest hepatoprotective effect seen in aging animals (Kuznik et al., Adv Gerontol 2020) [1].
- starKhavinson's foundational program describes a patented technology for producing tissue-specific peptide preparations from organ extracts and reports liver-selective activity of the resulting complexes and tetrapeptides, providing the mechanistic rationale for a liver-directed cytamin such as Svetinorm [2].
- starA 2021 systematic review concluded that short 2-7-residue peptides can penetrate the cell nucleus and regulate gene expression, the proposed pathway by which liver bioregulators would influence hepatocyte transcription, though it reports no human efficacy data for Svetinorm specifically [3].
- starAcross the broader bioregulator program, long-term treatment with peptide preparations increased mean lifespan by roughly 20-40% and suppressed spontaneous tumor development in rodents, supporting class-level geroprotection but not establishing benefit for the liver product in isolation [4].
- starA review of peptide bioregulators as a geroprotector class summarized decades of experimental data on prevention of age-related pathology in laboratory animals, again at the program level rather than for Svetinorm as a finished supplement [6].
- starThe strongest clinical signal for the Khavinson family comes from a 15-year randomized follow-up in which a pituitary/pineal peptide preparation slowed aging and lowered mortality in elderly patients; this studied a different peptide and cannot be extrapolated to Svetinorm [7].
- starNo randomized, placebo-controlled human trials of Svetinorm (Liver Cytomax A-7) as a finished product have been published; available human data are Russian observational reports and the product is marketed as a dietary supplement, so efficacy in people remains unproven [5][8].
Side Effects & Tolerability Profile
Clinical subjects transiently report mild side effects. Slowly escalating the titration dose represents the single most effective intervention to limit side effects.
- warningAcross decades of use in Russia, Khavinson cytamins including liver preparations are described as well tolerated with no serious adverse events reported, but there is no FDA-grade toxicology dossier, GLP safety pharmacology, or controlled drug-interaction data to back that claim [4][5].
- warningSvetinorm is an animal-tissue product (peptides extracted from calf and pig liver); people with bovine or porcine protein allergy should avoid it, and anyone uneasy about animal-sourced tissue extracts should note this origin [8].
- warningMild, transient gastrointestinal symptoms such as nausea or bloating can occur with oral peptide-complex capsules and are the most commonly mentioned tolerability issue.
- warningBecause the proposed mechanism is pro-proliferative gene modulation, use is theoretically inadvisable in active hepatic malignancy or other proliferative liver disease without specialist oversight.
- warningThe product has not been studied in pregnancy, lactation, or pediatric populations, and standard bioregulator guidance excludes these groups.
- warningThe subcutaneous route shown here is illustrative only; Svetinorm is manufactured as an oral capsule, and injecting a product not made for parenteral use carries real sterility, contamination, and injection-site risks, so capsule contents should never be self-injected.
- warningDrug-drug interactions have not been formally characterized; patients on hepatically cleared medications or with existing liver disease should monitor liver enzymes (ALT, AST, GGT, bilirubin) and consult a clinician, since this is an unapproved supplement rather than a tested medicine [4].
Subcutaneous Injection Technique
Most research peptides require subcutaneous injection into fatty tissue. Never inject directly into a blood vessel or deep muscle tissue unless clinically detailed.
1. Site Selection
Common locations include the abdomen (2 inches from navel), outer upper arms, or thighs.
2. Sanitization
Thoroughly clean the selected site, stopper and vial top using 70% isopropyl alcohol prep swabs.
3. Angle & Push
Pinch the skin and insert the needle at a 45 to 90-degree angle. Depress plunger smoothly.
4. Site Rotation
Rotate injection sites continuously to avoid lipodystrophy or tissue scarring.
Frequently Asked Questions
What is the typical Svetinorm dosage?expand_more
The established Svetinorm dosage is oral. Each capsule contains about 10 mg of the A-7 liver peptide complex, and the label directs adults to take 1-2 capsules once or twice daily with meals for a 30-day course, which can be repeated after 3-6 months [8]. That works out to roughly 10-40 mg of peptide complex per day. The subcutaneous schedule shown on this page (about 0.2-0.6 mg/day from a reconstituted 20 mg vial) is an educational reconstitution reference for the injectable cytomedin analog, not a clinically validated injectable dose.
Is Svetinorm FDA approved?expand_more
No. Svetinorm is not approved as a drug by the U.S. FDA, the EMA, or other major Western regulators, and there are no published randomized controlled trials of the finished product. It originates from Vladimir Khavinson's bioregulator program in Russia, where it is sold as a dietary supplement (cytamin). In the United States it falls under dietary-supplement or research-use framing and is not a medicine. Nothing here is a claim that it is safe or effective for treating any disease.
How is Svetinorm actually taken, and why does this page show subcutaneous injections?expand_more
Clinically Svetinorm is an oral enteric capsule taken with food; it is not an injectable product. To stay consistent with how this site presents reconstitution math, we also model an educational subcutaneous reference based on the lyophilized liver-cytomedin analog of the Khavinson class. Reconstituting a 20 mg vial with 2 mL of bacteriostatic water gives 10 mg/mL, so 2-6 units on a U-100 syringe equals 0.2-0.6 mg. Treat the injectable numbers as illustrative only and use the oral capsule protocol in practice.
What is the half life of Svetinorm?expand_more
Svetinorm's half-life has not been formally characterized. As a mixture of short peptides and amino acids, the intact molecules are expected to be hydrolyzed by gastrointestinal and plasma peptidases within minutes, giving a very short free-peptide plasma half-life [3]. The Khavinson framework attributes any lasting effect to downstream changes in gene expression that outlast the peptide itself, which is why the product is dosed in fixed 30-day courses repeated a few times a year rather than titrated to a half-life.
Can Svetinorm be stacked with other Khavinson bioregulators?expand_more
In the bioregulator literature, Svetinorm is routinely combined with other organ-specific peptides, for example Endoluten (neuroendocrine), Vladonix (immune), Cerluten (brain), Sigumir (joints/bone) and Ventfort (blood vessels), in 1-2 month cycles taken twice a year [8]. However, there are no controlled data on the safety, interactions, or added benefit of any such stack, and combining unapproved supplements multiplies the unknowns. This is general information, not medical advice; anyone considering these compounds should consult a qualified clinician.
Related Guides & Tools
Step-by-step references for reconstituting, measuring, and storing Svetinorm, plus the universal dosing calculator.
Academic References & Study Citations
Kuznik BI, Khasanova NB, Ryzhak GA, Meshcheriakova IE, Khavinson VK. The influence of polypeptide liver complex and tetrapeptide KEDA on organism physiological function in norm and age-related pathology. Adv Gerontol. 2020;33(1):159-164. View Scientific Paper →
Khavinson VK. Peptides and Ageing. Neuroendocrinol Lett. 2002;23 Suppl 3:11-144. View Scientific Paper →
Khavinson VK, Popovich IG, Linkova NS, Mironova ES, Ilina AR. Peptide Regulation of Gene Expression: A Systematic Review. Molecules. 2021;26(22):7053. View Scientific Paper →
Anisimov VN, Khavinson VK. Peptide bioregulation of aging: results and prospects. Biogerontology. 2010;11(2):139-149. View Scientific Paper →
Khavinson VK, Anisimov VN. Peptide regulation of aging: 35-year research experience. Bull Exp Biol Med. 2009;148(1):94-101. View Scientific Paper →
Khavinson VK, Kuznik BI, Ryzhak GA. [Peptide bioregulators: the new class of geroprotectors. Communication 1. Results of experimental studies]. Adv Gerontol. 2012;25(4):696-708. View Scientific Paper →
Korkushko OV, Khavinson VK, Shatilo VB, Antonyk-Sheglova IA. Peptide geroprotector from the pituitary gland inhibits rapid aging of elderly people: results of 15-year follow-up. Bull Exp Biol Med. 2011;151(3):366-369. View Scientific Paper →
Svetinorm (A-7 Liver Cytomax) - official Khavinson Peptide Products catalog: composition, indications and dosage. View Scientific Paper →